1. Home
  2. RNXT vs POCI Comparison

RNXT vs POCI Comparison

Compare RNXT & POCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • POCI
  • Stock Information
  • Founded
  • RNXT 2012
  • POCI 1982
  • Country
  • RNXT United States
  • POCI United States
  • Employees
  • RNXT N/A
  • POCI N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • POCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • RNXT Health Care
  • POCI Health Care
  • Exchange
  • RNXT Nasdaq
  • POCI Nasdaq
  • Market Cap
  • RNXT 31.6M
  • POCI 32.4M
  • IPO Year
  • RNXT 2021
  • POCI N/A
  • Fundamental
  • Price
  • RNXT $1.15
  • POCI $5.06
  • Analyst Decision
  • RNXT Strong Buy
  • POCI
  • Analyst Count
  • RNXT 1
  • POCI 0
  • Target Price
  • RNXT $9.00
  • POCI N/A
  • AVG Volume (30 Days)
  • RNXT 195.7K
  • POCI 8.6K
  • Earning Date
  • RNXT 03-31-2025
  • POCI 02-18-2025
  • Dividend Yield
  • RNXT N/A
  • POCI N/A
  • EPS Growth
  • RNXT N/A
  • POCI N/A
  • EPS
  • RNXT N/A
  • POCI N/A
  • Revenue
  • RNXT N/A
  • POCI $18,980,148.00
  • Revenue This Year
  • RNXT N/A
  • POCI N/A
  • Revenue Next Year
  • RNXT N/A
  • POCI N/A
  • P/E Ratio
  • RNXT N/A
  • POCI N/A
  • Revenue Growth
  • RNXT N/A
  • POCI N/A
  • 52 Week Low
  • RNXT $0.77
  • POCI $3.47
  • 52 Week High
  • RNXT $1.86
  • POCI $6.90
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 58.08
  • POCI 51.60
  • Support Level
  • RNXT $1.32
  • POCI $4.75
  • Resistance Level
  • RNXT $1.40
  • POCI $5.19
  • Average True Range (ATR)
  • RNXT 0.11
  • POCI 0.15
  • MACD
  • RNXT 0.00
  • POCI 0.01
  • Stochastic Oscillator
  • RNXT 39.47
  • POCI 58.49

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About POCI Precision Optics Corporation Inc.

Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.

Share on Social Networks: